HOME >> MEDICINE >> NEWS
Chemotherapy with bevacizumab increases risk of blood clots in arteries

Treatment with chemotherapy and bevacizumab, an anticancer drug, is associated with a greater risk of blood clots in patients arteries compared with treatment with chemotherapy only, according to a study published online August 7 in the Journal of the National Cancer Institute.

The combination of chemotherapy and bevacizumab has been shown to increase survival in patients with metastatic colorectal and nonsmall-cell lung cancer, but some previous studies suggest these patients are at an increased risk for blood clots in their arteries.

Frank Scappaticci, M.D., Ph.D., of Genentech, Inc. in South San Francisco, Calif., and colleagues analyzed data from five randomized controlled trials that included 1,745 patients with metastatic colorectal, breast, or nonsmall-cell lung cancer.

Among patients treated with the combination therapy, 3.8 percent experienced blood clots in their arteries, compared with 1.7 percent of patients on chemotherapy alone. There was no statistically significant difference in the incidence of blood clots in veins. Risk factors for blood clots in both arteries and veins included previous blood clots and older age (65 or older.)

The clinical benefit associated with bevacizumab therapy was maintained for all subgroups. Although death from [a blood clot in the artery] was uncommon, we did not capture functional disabilities from these events, and the risk factorsidentified in this study should be considered when making treatment decisions for individual patients, the authors write.


'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
7-Aug-2007


Page: 1

Related medicine news :

1. Chemotherapy may enhance the effectiveness of brain tumor vaccines
2. Chemotherapy more effective when given before breast cancer surgery
3. Chemotherapy temporarily affects the structures of the human brain
4. Chemotherapy gel may fight breast cancer and reduce breast deformity
5. Chemotherapy given directly to the liver improves survival for patients with colorectal cancer
6. Chemotherapy after surgery extends survival for patients with advanced endometrial cancer
7. Chemotherapy errors rare, but have potential for serious consequences
8. Chemotherapy for brain tumors is boosted after vaccine targets resistance-related antigen
9. Chemotherapy options improve for patients with advanced colorectal cancer
10. Reduced greenhouse gas emissions required to avoid dangerous increases in heat stress
11. Risk of Parkinsons disease increases with pesticide exposure and head trauma

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/13/2019)... ... 2019 , ... The Oncology Institute of Hope and Innovation ... 5380 S. Rainbow Blvd., Suite 210, Las Vegas, NV 89118. It is conveniently ... with state-of-the-art medical equipment plus all of the top-notch care already offered in ...
(Date:7/13/2019)... ... ... The American Med Spa Association (AmSpa) has released the 2019 Medical Spa State ... spa professionals understand the realities of the industry and make better, more informed decisions ... AmSpa released the 2017 Medical Spa State of the Industry Report and so much ...
(Date:7/11/2019)... ... 11, 2019 , ... The International Society for Pharmaceutical ... of features to further advance their mission of delivering technical and operational solutions ... for patients worldwide. The latest additions include a new ISPE official video page, ...
(Date:7/10/2019)... ... July 10, 2019 , ... HMP, a leader in healthcare events ... the Oncology Clinical Pathways Congress, taking place October 11-13, 2019 in Boston. , Launched ... and focuses on the expansion of clinical pathways as a decision support tool and ...
(Date:7/9/2019)... ... ... excited to offer laser vaginal rejuvenation. Laser vaginal rejuvenation gives women a less painful and ... painful sex , vaginal dryness and burning , vaginal atrophy , ... vaginal pH imbalances , recurrent vaginal infections , vaginal and vulvar ...
Breaking Medicine News(10 mins):
(Date:7/9/2019)... N.Y. (PRWEB) , ... July 09, 2019 , ... ... produces original therapeutic play products for children with adaptive needs, has received the ... company partners with occupational therapists, parents, designers and others to develop, test and ...
(Date:7/9/2019)... ... 2019 , ... HealthTalk A.I. , a leading patient ... made the announcement at the recent PX2019 Patient Experience Conference in Dallas. HealthTalk ... as well as tools to better evaluate staff performance and recover dissatisfied patients. ...
(Date:7/9/2019)... ... July 09, 2019 , ... ... Porus Lifesciences (Bangalore, India), today announced the raise of its Series A funding. ... Avammune also announced the appointment of its scientific advisory board comprised of: , ...
Breaking Medicine Technology:
Cached News: